Physician profile
John W East
NPI 1588623706
$3,368.00
in general payments reported to CMS, 2019-2025
19 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $874 · 2021: $627 · 2022: $635 · 2023: $47.40 · 2024: $140 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,693.94 | 2019-2022 | |
| Merz North America, INC. | $825.40 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $232.12 | 2022-2025 | Relistor |
| Ibsa Pharma INC. | $97.92 | 2021-2022 | |
| Abbvie INC. | $89.15 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $65.09 | 2019-2024 | Xtampza |
| Assertio Therapeutics, INC. | $54.71 | 2019 | |
| Allergan, INC. | $47.12 | 2019-2022 | |
| Almatica Pharma LLC | $45.80 | 2021 | |
| Depuy Synthes Sales INC. | $44.09 | 2020-2023 | Orthovisc, Monovisc |
| Boston Scientific Corporation | $31.15 | 2025 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $23.44 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.49 | 2025 | |
| Forte Bio-Pharma LLC | $18.77 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $17.30 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $16.76 | 2025 | Hymovis, Triluron |
| Abbott Laboratories | $16.54 | 2021 | |
| Pfizer INC. | $14.94 | 2021 | |
| Zyla Life Sciences, INC. | $13.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John East listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.